Article
Transmitted Antiretroviral Drug Resistance to Integrase Strand Transfer Inhibitors Class in São Paulo Metropolitan Area, Brazil.
AIDS research and human retroviruses - 1 Dec 2024
Matsuda Elaine Monteiro, da Silva Santos Jaqueline Helena, Ahagon Cintia Mayumi, López-Lopes Giselle Ibete Silva, Brígido Luís Fernando de Macedo
Abstract excerpt
A newer integrase strand transfer inhibitor (INSTI) cabotegravir was recently approved for both therapy and prophylaxis and can play an essential role in the fight against AIDS. It shares similar resistance profile to dolutegravir, the cornerstone of Brazilian antiretroviral (ARV) treatment, with about 600 thousand people living with HIV in Brazil currently on regimens that contain this INSTI. Health services in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
